enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Warfarin - Wikipedia

   en.wikipedia.org/wiki/Warfarin

   Warfarin is indicated for the prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism; [9] prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement; [9] and reduction in the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after ...

3. Deep vein thrombosis - Wikipedia

   en.wikipedia.org/wiki/Deep_vein_thrombosis

   Imaging is also needed for hospital inpatients with suspected DVT and those initially categorized as unlikely to have DVT but who have a positive D-dimer test. [1] While the Wells score is the predominant and most studied clinical prediction rule for DVT, [39] [115] it does have drawbacks. The Wells score requires a subjective assessment ...

4. Anticoagulant - Wikipedia

   en.wikipedia.org/wiki/Anticoagulant

   An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.

5. Thrombosis prevention - Wikipedia

   en.wikipedia.org/wiki/Thrombosis_prevention

   If you're at risk for DVT, talk to your doctor about: Graduated compression stockings (sometimes called "medical compression stockings") Medication (anticoagulants) to prevent DVT. When sitting for long periods of time, such as when traveling for more than four hours: Get up and walk around every 2 to 3 hours.

6. Direct thrombin inhibitor - Wikipedia

   en.wikipedia.org/wiki/Direct_thrombin_inhibitor

   Ximelagatran showed good efficacy compared with warfarin in several trials in prevention and treatment of deep vein thrombosis and as thromboprophylaxis in atrial fibrillation. [1] Development was stopped by manufacturer AstraZeneca , however, because of reports of liver enzyme derangements and liver failure .

7. Low-molecular-weight heparin - Wikipedia

   en.wikipedia.org/wiki/Low-molecular-weight_heparin

   Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. [1] They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.